These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12093497)

  • 1. Simultaneous determination of fexofenadine and its related compounds by HPLC.
    Radhakrishna T; Om Reddy G
    J Pharm Biomed Anal; 2002 Jul; 29(4):681-90. PubMed ID: 12093497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules.
    Breier AR; Paim CS; Menegola J; Steppe M; Schapoval EE
    J AOAC Int; 2004; 87(5):1093-7. PubMed ID: 15493665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
    Karakuş S; Küçükgüzel I; Küçükgüzel SG
    J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
    Oliveira DC; Weigch A; Rolim CM
    Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary electrophoresis method for fexofenadine hydrochloride in capsules.
    Breier AR; Garcia SS; Jablonski A; Steppe M; Schapoval EE
    J AOAC Int; 2005; 88(4):1059-63. PubMed ID: 16152920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDENTIFICATION AND DETERMINATION OF RUPATADINE AND FEXOFENADINE BY DENSITOMETRIC METHOD.
    Czerwinska K; Wyszomirska E; Kublin E; Malanowic E; Mazurek AP
    Acta Pol Pharm; 2016 Nov; 73(6):1467-1474. PubMed ID: 29634100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
    Jaber AM; Al Sherife HA; Al Omari MM; Badwan AA
    J Pharm Biomed Anal; 2004 Oct; 36(2):341-50. PubMed ID: 15496327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC.
    Arayne MS; Sultana N; Mirza AZ; Siddiqui FA
    J Chromatogr Sci; 2010; 48(5):382-5. PubMed ID: 20515533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets.
    Maher HM; Sultan MA; Olah IV
    Chem Cent J; 2011 Dec; 5(1):76. PubMed ID: 22136482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry.
    Hofmann U; Seiler M; Drescher S; Fromm MF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):227-33. PubMed ID: 11824810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of pantoprazole and its main impurities in pharmaceuticals.
    Letica J; Marković S; Zirojević J; Nikolić K; Agbaba D
    J AOAC Int; 2010; 93(4):1121-8. PubMed ID: 20922942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of a ternary mixture of doxylamine succinate, pyridoxine hydrochloride, and folic acid by the ratio spectra-zero-crossing, double divisor-ratio spectra derivative, and column high-performance liquid chromatographic methods.
    Pathak A; Rajput SJ
    J AOAC Int; 2008; 91(5):1059-69. PubMed ID: 18980119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC Determination of Fexofenadine in Human Plasma For Therapeutic Drug Monitoring and Pharmacokinetic Studies.
    Helmy SA; El Bedaiwy HM
    Biomed Chromatogr; 2016 Jul; 30(7):1059-1064. PubMed ID: 26577375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography.
    Miura M; Uno T; Tateishi T; Suzuki T
    J Pharm Biomed Anal; 2007 Jan; 43(2):741-5. PubMed ID: 16934428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection.
    Uno T; Yasui-Furukori N; Takahata T; Sugawara K; Tateishi T
    J Pharm Biomed Anal; 2004 Jun; 35(4):937-42. PubMed ID: 15193739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel membrane sensor for histamine H1-receptor antagonist "fexofenadine".
    Abbas MN; Abdel Fattah AA; Zahran E
    Anal Sci; 2004 Aug; 20(8):1137-42. PubMed ID: 15352500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantitation of Ofloxacin, Fexofenadine HCl and Diclofenac Potassium in affixed dose combinative formulation by HPLC-UV method.
    Salam FA; Shoaib MH; Yousuf RI; Sultan F; Khan MA; Manzoor S
    Pak J Pharm Sci; 2015 Nov; 28(6):1979-84. PubMed ID: 26639475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatographic determination of cetirizine in oral formulations.
    Bajerski L; Cardoso SG; Diefenbach IF; Malesuik MD; Sílvia H; Borgmann M
    J AOAC Int; 2005; 88(2):424-7. PubMed ID: 15859066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of pyridoxine hydrochloride and doxylamine succinate from tablets by ion pair reversed-phase high-performance liquid chromatography (RP-HPLC).
    Argekar AP; Sawant JG
    Drug Dev Ind Pharm; 1999 Aug; 25(8):945-50. PubMed ID: 10434138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.